skip to navigation skip to content

Cambridge News: Amadeus Capital backs Healx with £1.5m investment


Healx, a start-up researching innovative uses of existing medicines, has raised £1.5m that will help find cures for rare disease sufferers around the world. Healx chief executive Tim Guilliams, said: “By repurposing existing drugs to combat rare diseases, Healx is able to find potential treatments at a fraction of the cost and in a much shorter timeframe than developing a new drug.” The start-up is supported by the Accelerate Cambridge programme at Cambridge Judge’s Entrepreneurship Centre.

Read the full article []